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The limited regeneration capacity of the adult central nervous system (CNS) requires
strategies to improve recovery of patients. In this context, the interaction of endogenous
as well as transplanted stem cells with their environment is crucial. An understanding of
the molecular mechanisms could help to improve regeneration by targeted manipulation. In
the course of reactive gliosis, astrocytes upregulate Glial fibrillary acidic protein (GFAP) and
start, in many cases, to proliferate. Beside GFAP, subpopulations of these astroglial cells
coexpress neural progenitor markers like Nestin. Although cells express these markers,
the proportion of cells that eventually give rise to neurons is limited in many cases in vivo
compared to the situation in vitro. In the first section, we present the characteristics of
endogenous progenitor-like cells and discuss the differences in their neurogenic potential
in vitro and in vivo. As the environment plays an important role for survival, proliferation,
migration, and other processes, the second section of the review describes changes
in the extracellular matrix (ECM), a complex network that contains numerous signaling
molecules. It appears that signals in the damaged CNS lead to an activation and de-
differentiation of astrocytes, but do not effectively promote neuronal differentiation of
these cells. Factors that influence stem cells during development are upregulated in
the damaged brain as part of an environment resembling a stem cell niche. We give a
general description of the ECM composition, with focus on stem cell-associated factors
like the glycoprotein Tenascin-C (TN-C). Stem cell transplantation is considered as potential
treatment strategy. Interaction of transplanted stem cells with the host environment is
critical for the outcome of stem cell-based therapies. Possible mechanisms involving the
ECM by which transplanted stem cells might improve recovery are discussed in the last
section.
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INTRODUCTION
Regeneration of the adult central nervous system (CNS) after
damage is limited in mammals. This causes severe problems for
patients who suffer from CNS lesions or stroke. Regeneration of
the peripheral nervous system is more effective, differences in
the cellular response are attributed to this discrepancy (Brosius
Lutz and Barres, 2014). Several approaches have been tested in
animal models to improve functional recovery of patients, for
instance neutralization of inhibitory factors by injection of block-
ing antibodies or by enzymatic degradation (Zhao et al., 2013).
Transplantation of stem cells are another promising strategy and
effort is made to examine their effect on regeneration in clinical
trials (Savitz et al., 2014). For an efficient treatment, an under-
standing of the cellular and molecular mechanisms underlying the
observed limitations is of interest.
In the first section we describe the effect of CNS damage on
astrocytes that become reactive and in many cases start to re-
express neural progenitor markers. The second section is focused
on the extracellular matrix (ECM) and factors in this matrix
expressed by these astrocytes and other cell types. The third
section is dedicated to the question how transplanted stem cells
can interact with the host and by which mechanisms they might
improve regeneration.
LESIONS OF THE CENTRAL NERVOUS SYSTEM ACTIVATE
ENDOGENOUS PROGENITOR-LIKE CELLS
After stroke or lesion, astrocytes, microglia, and other cell types of
the immune system are activated in a process called reactive gliosis
(reviewed by Donnelly and Popovich, 2008; Burda and Sofroniew,
2014). Astrocytes change their morphology and subpopulations
of them upregulate markers typical of immature neural progeni-
tors during development (Figure 1). In severe cases, a glial scar is
formed by astrocytes that intermingle with fibroblasts before they
segregate (Bundesen et al., 2003). In the following first section
of the review, we want to give a short overview of the markers
these astroglial subtypes express, of their spatial distribution and
origin, and of the neurogenic potential these cells might have
in vivo.
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FIGURE 1 | Subtypes of reactive astroglia. (A, B) Astrocytes become
reactive following CNS damage. In addition to GFAP upregulation, some
of the cells start to express progenitor markers like Vimentin and Nestin.
The position of the cells in relation to the lesion determines the
expression pattern with Nestin near the lesion, Vimentin in a broader
area and GFAP with a widespread upregulation. (C)
Immunohistochemical staining of GFAP (red), Vimentin (green), and
Nestin (blue, in an adjacent slice) expression after focal laser lesion of
the mouse visual cortex. The dashed line depicts the border to the lesion
core; * lesion core.
PROGENITOR MARKER EXPRESSION AFTER CNS DAMAGE
Astrocytes become reactive after CNS damage and typically
express the intermediate filament Glial fibrillary acidic protein
(GFAP). In addition, other markers like the intermediate fila-
ments Vimentin and Nestin are coexpressed (Pekny and Nilsson,
2005). Vimentin is expressed in radial glia during development
(Bignami et al., 1982), whereas Nestin is the prototypical neural
stem/progenitor cell marker (Lendahl et al., 1990). Depending on
the time point after lesion, additional markers for immature glia
like Brain lipid-binding protein (BLBP), the DSD-1 epitope on
members of the receptor protein tyrosine phosphatase (RPTP)
β family, and Tenascin-C (TN-C) are expressed (Robel et al.,
2011).
The function of GFAP and Vimentin in regeneration is
discussed (Brenner, 2014). For example, knockout mice deficient
for GFAP and Vimentin showed reduced hypertrophy of
astrocytes, improved synaptic restoration after entorhinal cortex
lesion (Wilhelmsson et al., 2004), and supported integration of
cells transplanted into the retina (Kinouchi et al., 2003) or into the
hippocampus (Widestrand et al., 2007). In contrast, an increased
lesion volume was found in GFAP/Vimentin double knockout
mice after stroke, whereas single knockouts had no effect on
the lesion volume (Li et al., 2008). Different GFAP isoforms are
described for human and mice, but especially for mice there is
no clear correlation of certain isoforms with stem/progenitor
cells (Kamphuis et al., 2012). The role of TN-C and other ECM
components in regeneration is discussed in the second section.
ASTROGLIAL SUBTYPES ARE ARRANGED IN DISTINCT AREAS
The different markers mentioned above are not uniformly
expressed by all astrocytes. Instead, subpopulations express
different combinations. Here it was observed that the cells show
a specific spatial distribution. For example, focal laser lesions in
the adult mouse visual cortex (Roll et al., 2012) induce GFAP
upregulation in a wide area, whereas the progenitor markers
Vimentin and even more extremely Nestin are restricted to an
area near the lesion core (Figure 1). Interestingly, astrocytes (type
B cells) are the stem cells of the subventricular zone (SVZ) and
are also positive for Nestin and Vimentin (Doetsch et al., 1997,
1999). Differences in marker expression may reflect the potential
of the cells to form other neural cell types. It was described
that multipotent neural stem/progenitor cells that give rise to
neurons, astrocytes, and oligodendrocytes in vitro appear in the
brain following stab wound (Buffo et al., 2008), laser lesion (Sirko
et al., 2009), and in other lesion models (Sirko et al., 2013). As
shown by differential marker expression, reactive astrocytes are
a heterogeneous population with respect to the distance of a
cell to the lesion. Additionally, astrocytes are also heterogeneous
regarding morphology, function, CNS region, and severity of the
lesion (reviewed by Anderson et al., 2014).
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DIFFERENT ORIGINS OF MULTIPOTENT CELLS AFTER CNS DAMAGE
An obvious question regarding multipotent stem/progenitor cells
in the damaged adult brain is the origin of those cells. Are adult
stem cells attracted from the stem cells niches like the SVZ and
migrate to the lesion site, or are local astrocytes induced to de-
differentiate on-site? An argument for activation of local cells
in focal laser lesions of the visual mouse cortex is the distinct
spatial distribution of markers like GFAP, Vimentin, and Nestin.
A similar finding of Nestin-expressing cells in a distinct pattern
was made in the spinal cord after hemitransection and was also
interpreted as local activation (Lang et al., 2004). Re-expression of
the ECM molecule TN-C, which is expressed during development
and later downregulated in the adult cortex, is also restricted to
astrocytes located near the lesion (McKeon et al., 1991; Roll et al.,
2012). It can be assumed that gradients of signaling molecules
with high concentrations near the lesion and decreasing levels in
the periphery influence the cell fate and result in the observed
regional differences. Indeed, fate mapping studies by Buffo et al.
(2008) showed that stab wounds activate local astrocytes in the
cortex that are multipotent in vitro. Multipotent cells that give
rise to neurons, astrocytes, or oligodendrocytes can be found in
the developing nervous system. Different tripotential, but also
subtypes of bipotential glial precursors have been described there.
For example, glial restricted precursors (GRPs) that produce
oligodendrocytes and astrocytes, O2A cells that give rise to oligo-
dendrocytes and type-2 astrocytes, and others are distinguished
according to their potential in vivo and in vitro and to their marker
expression (Liu and Rao, 2004). The proteoglycan Neuron-glial
antigen 2 (NG2) is associated with glial precursors during devel-
opment, therefore the contribution of NG2-positive cells present
in the adult CNS after damage is discussed (Han et al., 2004;
Komitova et al., 2011). In the spinal cord, it has been shown
that ependymal cells contribute significantly to newly formed
astrocytes and show multilineage potential (Barnabé-Heider et al.,
2010). To what extent cells after damage only share similarities
or if they acquire a cell fate that is indeed identical to those
developmental populations is hard to determine. Depending on
the severity, in addition to a local response cells from the adult
stem cell niches are activated (Shimada et al., 2010). A stem
cell response in terms of an increased SVZ size (Thored et al.,
2006) and attraction of neuroblasts from the SVZ to the stria-
tum after stroke was reported (Arvidsson et al., 2002; Yamashita
et al., 2006). Regional differences in the potential of SVZ cells
are described, such as dorsolateral prevalence of oligodendroglial
cells and neuronal and astroglial fates in the ventrolateral area
(reviewed by Maki et al., 2013). In some cases, attraction of cells
from the SVZ could not be shown by cell tracing experiments
(Shimada et al., 2012) or fate mapping (Buffo et al., 2008). In
contrast to the described promoting effects of stroke on the
adult stem cell niche, chronic inflammation reduces proliferation
and impairs migration of neuroblasts (Pluchino et al., 2008).
So in general, local activation as well as an influence on the
existing adult stem cell niches are conceivable and may take
place in parallel. Certainly, this depends on the type, severity,
and localization of the damage and further studies are needed
to determine the contribution of both mechanisms in different
lesion paradigms.
DIFFERENCES OF THE NEUROGENIC POTENTIAL IN VIVO AND IN VITRO
In many cases, the neurogenic potential of the cells in vivo is
more restricted compared to the situation in vitro. So reactive
astrocyte-derived cells appear to be multipotent in culture, but
fail to form neurons after transplantation in vivo (Shimada et al.,
2012). An approach to promote the neuronal fate of reactive astro-
cytes is retroviral expression of the proneural transcription factor
NeuroD1, allowing astrocytes to differentiate into glutamatergic
neurons (Guo et al., 2014). Another transcription factor, Sox2,
was able to convert spinal cord astrocytes into neurons (Su et al.,
2014). A further strategy is the administration of neurogenesis-
promoting factors, as shown for Galectin-1 after stroke (Ishibashi
et al., 2007). More strategies have been summarized by Obermair
et al. (2008).
The main difference between endogenous stem/progenitor
cells in situ and their isolated and cultured counterparts is the
completely changed environment, where signals from other cell
types are lost. Among them are several neurogenesis-inhibiting
factors (Seidenfaden et al., 2006; Buddensiek et al., 2009), one
of the candidates is Notch (Aruga et al., 2002). Stress during
isolation, high concentrations of growth factors in the medium,
and the oxygen and energy supply are additional factors that may
influence the cells’ potential. This shows that both, multipotent
cells combined with a permissive environment, are necessary
for the formation of neurons after lesion. The ECM contains
a tremendous variety of signaling molecules and with regard
to its importance for regeneration it is the topic of the next
section.
EXTRACELLULAR SIGNALS INFLUENCE REGENERATION AND
STEM/PROGENITOR CELLS
The ECM is a complex network of interacting molecules that
are secreted by the cells into the extracellular space. Depending
on the tissue, it functions as a scaffold for the cells and provides
mechanical stability, for example in cartilage (Treilleux et al.,
1992), but also in all other tissues. The ECM in the CNS is
free of fibrillar elements, except after lesion (Heck et al., 2007).
It contains glycoproteins like TN-C, TN-R, and proteoglycans
(PG; Zimmermann and Dours-Zimmermann, 2008). PGs
consist of a core protein and covalently attached carbohydrate
(glycosaminoglycan, GAG) chains. Important Chondroitin
sulfate proteoglycans (CSPGs) are molecules of the Lectican
family and members of the RPTPβ family, whereas the Heparan
sulfate proteoglycans (HSPGs) Syndecan and Glypican are other
prominent constituents. Interactions of PGs with other molecules
can be mediated by the core protein or by the carbohydrate
structures. The ECM is able to bind growth factors and to present
them to the cells (Clark, 2008; Brizzi et al., 2012). This allows the
extracellular signals to regulate processes like cell survival, prolif-
eration, and differentiation as well as migration or axon growth.
According to changing requirements during development, the
ECM composition is variable. After CNS lesions, the ECM is
altered again. For example, reactive gliosis can lead to a glial scar
that has a beneficial effect as it provides a barrier for healthy tissue
from the environment (Pekny et al., 2014). At the same time, it is
the major obstacle for axonal regrowth (Silver and Miller, 2004;
Rolls et al., 2009). But the ECM is more than one constituent of
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the glial scar. It is involved in synaptic plasticity in many ways, for
example in long term potentiation (LTP; Dityatev and Schachner,
2003). As mentioned above, the ECM contains signals regulating
processes that are critical for regeneration and therefore this
second section of the review is dedicated to details regarding the
ECM composition and associated factors after CNS damage.
EXTRACELLULAR MATRIX AFTER CNS DAMAGE
After lesion, several aspects of extracellular signals are criti-
cal: (i) barriers like the glial scar are important to protect the
healthy tissue from the environment, but they also prevent axonal
regrowth or cell migration; (ii) plasticity-limiting factors stabilize
neuronal networks in the healthy brain but exacerbate reorga-
nization in case of damage; and (iii) the balance between de-
differentiation and re-differentiation. If cells are induced by the
extracellular signals to de-differentiate, but get no signal for
proper differentiation, they will stay in an undifferentiated state
and cannot replace lost tissue. For example, TN-C, which is also
present in the adult stem cell niche, may inhibit differentiation
of an astrocyte-derived progenitor cell into a functional neuron
or oligodendrocyte. This could be mediated by repression of the
RNA-binding molecule Sam68 (Moritz et al., 2008; Czopka et al.,
2010).
Extracellular matrix under different pathological conditions
Changes in the ECM composition differ depending on the type
of CNS damage. As a disease-specific description is not the aim
of this review, we recommend the following publications: stroke-
induced effects were reviewed by Ellison et al. (1999), with focus
on the blood-brain barrier by Baeten and Akassoglou (2011).
Reports are also available for brain tumors (Gladson, 1999; Wade
et al., 2013), spinal cord injuries (Condic and Lemons, 2002), neu-
rodegenerative diseases like Alzheimer’s (Morawski et al., 2012),
and for autoimmune disorders like multiple sclerosis (Sobel, 1998;
van Horssen et al., 2007).
SOURCES OF EXTRACELLULAR MATRIX AND ASSOCIATED SIGNALING
MOLECULES
In response to damage, a number of cell types react and com-
municate via extracellular signals. The main sources of ECM
and related important signaling molecules in the matrix are
summarized in this paragraph. Important sources of extracellular
molecules are listed in Table 1.
Vasculature
Blood vessels are an important signal source, as reviewed by
Gattazzo et al. (2014). As part of the neurovascular niche they
are also thought to be crucial for the residing stem/progenitor
cells in the adult stem cell niches (Shen et al., 2008). Endothelial
cells produce a number of factors that act on neural cells. Among
others, Pleiotrophin, Leukaemia inhibitory factor (LIF), Brain-
derived neurotrophic factor (BDNF), and Fibroblast growth fac-
tor (FGF) 2 influence differentiation (Carmeliet, 2003; Dugas
et al., 2008). Vascular endothelial growth factor (VEGF) is an
important regulator of angiogenesis and neurogenesis (Jin et al.,
2002; Nag et al., 2002). Angiogenesis is increased in the damaged
CNS and therefore more cells get in contact with the perivascular
Table 1 | Important sources of extracellular signaling molecules after
CNS lesion.
Cell type Extracellular matrix-related molecule
Endothelial cells Brain-derived neurotrophic factor (BDNF)
Fibroblast growth factor 2 (FGF2)
Leukaemia inhibitory factor (LIF)
Pleiotrophin
Vascular endothelial growth factor (VEGF)
Fibrinogen [blood-derived]
Pericytes Fibronectin
Astrocytes Agrin
Brevican
Collagen IV, VIII
Decorin
Fibronectin
Glypican
Laminin
Neurocan
Phosphacan
Syndecan
Tenascin-C
Thrombospondin
Versican
Oligodendrocytes/ Matrix metalloproteinase 9 (MMP-9)
Precursors Neurocan
Neuron-glial antigen 2 (NG2)
Nogo-A
Versican
Neurons Chemokines
Cytokines
Sonic hedgehog (SHH)
Microglia/Macrophages Cytokines
Neuron-glial antigen 2 (NG2)
Neurotrophic factors
As the origin of secreted molecules is often difficult to determine by immuno-
logical studies, more molecules are expressed that have not yet been allocated.
References are given in the text.
niche (Arai et al., 2009). Hypoxia supports stemness during
development, but also under pathological conditions like stroke
(Panchision, 2009). This is mediated by Hypoxia-inducible factor
(HIF) I α, which facilitates Notch signaling and inhibits factors
responsible for differentiation, for example Bone morphogenetic
proteins (BMPs). The blood-brain barrier is disrupted in many
cases as result of mechanical damage or chemokines (Dimitrijevic
et al., 2006), which allows cells like T lymphocytes and additional
factors from the blood to enter the CNS that are retained under
normal conditions. When Fibrinogen from the blood crosses the
disturbed blood-brain barrier, it activates astrocytes by providing
Transforming growth factor β (TGF-β; Schachtrup et al., 2010).
Pericytes are involved in the production of the glial scar, including
Fibronectin (FN; Göritz et al., 2011). In addition, vessels are
used as guiding structures by migrating neural progenitors in the
healthy and diseased brain (Massouh and Saghatelyan, 2010).
Astrocytes
Astrocytes are extremely heterogeneous in their expression
profile, as described in the first section. Depending on the type
of damage, the time point after lesion, and the position, reactive
astrocytes are responsible for TN-C expression in many lesion
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models (McKeon et al., 1991; Roll et al., 2012) and also express
Brevican, Versican (Beggah et al., 2005), Neurocan (Haas et al.,
1999), Phosphacan (McKeon et al., 1999), Decorin (Stichel et al.,
1995), Laminin, and FN (Gris et al., 2007). HSPGs expressed by
reactive astrocytes are Glypican, Syndecan, and Agrin (Iseki et al.,
2002; Hagino et al., 2003; Falo et al., 2008). Collagen expression,
which is involved in glial scar formation, was also shown for
reactive astrocytes. The basement membrane-associated type IV
(Liesi and Kauppila, 2002) and type VIII (Hirano et al., 2004)
Collagens were detected. Astrocytes are also a source of Throm-
bospondins (TSPs; Lin et al., 2003) (reviewed by Sofroniew,
2009). Astrocytic expression of TN-C, Neurocan, and Phosphacan
is increased by presence of meningeal fibroblasts in vitro (Wan-
ner et al., 2008). Activation of astrocytes is mediated by pro-
inflammatory cytokines like Interleukin (IL)-1β, IL-6, and Tumor
necrosis factor α (TNF-α). They are secreted by microglia, in part
by the astrocytes themselves, or by other cell types (Buffo et al.,
2010).
Oligodendrocytes
Oligodendrocytes produce Nogo-A, an inhibitor of neurite out-
growth (Chen et al., 2000). Oligodendrocyte precursors express
the CSPGs Neurocan and NG2 (Levine, 1994; Asher et al., 2000)
and oligodendrocyte lineage cells secrete Versican under patho-
logical conditions (Asher et al., 2002). Matrix metalloproteinase
9 (MMP-9) produced by oligodendrocyte precursors leads to
blood-brain barrier leakage (Seo et al., 2013).
Neurons
Neurons start to express numerous chemokines like Chemokine
(C-C motif) ligand 20 (CCL20), CCL21, CXC chemokine lig-
and 12 (CXCL12/SDF-1), and CXCL14/BRAK under pathological
conditions (Das et al., 2012). They are primarily involved in
immunomodulation, but additional functions as neuromodula-
tors are assumed (Rostène et al., 2011).
Microglia
Microglia, the macrophages of the CNS, are activated by several
mechanisms after injury. For example, they can detect reduced
neuronal activity by alterations in neurotransmitter concentra-
tion and become activated (Biber et al., 2007; Kettenmann et al.,
2011). Chemokines expressed after lesion can induce migration
of microglia, for example Cysteine-cysteine (CC) chemokines
(Carbonell et al., 2005). The consequence of microglial activa-
tion is the upregulation of cytokines and neurotrophic factors
(Donnelly and Popovich, 2008). Increased levels of cytokines
can induce remodeling of the ECM, for example by induc-
ing the expression of MMPs (Gottschall and Yu, 1995) and of
matrix molecules like TN-C by reactive astrocytes. Activated
microglia also express ECM molecules themselves, for example
NG2 (Sugimoto et al., 2014).
CLASSES OF EXTRACELLULAR MATRIX MOLECULES IN THE
POSTLESIONAL CNS
Important classes of extracellular signaling molecules that are
typically present after CNS damage are described below. In many
cases, components typical of the stem cell niches are re-expressed
and provide an environment that resembles—in part—a neural
stem cell niche like the SVZ. That niche is formed by signals
from the vasculature, cerebrospinal fluid, and a complex set of
extracellular molecules secreted by the cells in the niche (reviewed
by Kazanis and ffrench-Constant, 2011). The situation after lesion
with upregulated ECM molecules and the niche-like environment
is summarized in Figure 2. As described above, major sources of
the signals are reactive astrocytes, microglia, and the vasculature.
Important functions regulated by ECM molecules and associated
factors are listed in Table 2.
Chondroitin sulfate proteoglycans
CSPGs act as barrier after CNS damage and contribute to the
axonal growth-inhibitory environment including the glial scar
(Brown et al., 2012). CSPGs are mainly expressed by reactive
astrocytes. Their effect can be mediated by members of the
Leukocyte common antigen-related (LAR) family of RPTPs that
comprises for example LAR, RPTPδ, RPTPσ, and the Nogo recep-
tors NgR1 and NgR3 (reviewed by Cregg et al., 2014). LARs are
involved in β-Catenin recruitment, leading to changes in the Actin
cytoskeleton, which in turn affects axon growth and synaptic
organization (Um and Ko, 2013). The Actin cytoskeleton is also
targeted by NgR1 and coreceptors, in this case via the small
GTPase RhoA and Rho-associated kinase (ROCK; Fournier et al.,
2003; Schwab and Strittmatter, 2014). In addition to the above
mentioned receptors, CSPGs can bind to specific receptors like
Integrins, a family of heterodimeric transmembrane receptors
(see the detailed Integrin description below). CSPGs can also act
indirectly, when they intensify growth factor-induced signaling
by presenting a growth factor to its receptor, or conversely, block
signaling by sequestering growth factors like Pleiotrophin (Deepa
et al., 2002) from their receptors (reviewed by Carulli et al.,
2005; Sharma et al., 2012b). Neurocan, Brevican, and Versican
levels are increased after lesion (Jones et al., 2003; Beggah et al.,
2005) as well as Biglycan, Decorin (Stichel et al., 1995), and
NG2 (Levine, 1994). NG2 inhibits neurite outgrowth, conse-
quently its neutralization improves recovery (Dou and Levine,
1994; Petrosyan et al., 2013). It is produced by oligodendrocyte
progenitors, but not by GFAP-positive astrocytes. This is in line
with reports that NG2-positive progenitors are not an important
source of astrocytes after brain injury (Komitova et al., 2011).
Macrophages and microglia are additional sources of NG2 (Jones
et al., 2002; Sugimoto et al., 2014). Decorin antagonizes scar
formation as it is able to reduce the expression of Neurocan,
Brevican, NG2, and Phosphacan, probably by inhibiting TGF-
β and antagonizing the Epidermal growth factor (EGF) recep-
tor (Davies et al., 2004). The RPTPβ (or “RPTPβ/ζ“) family
comprises four isoforms. Alternative splicing of a single gene
and proteolytic processing result in two transmembrane recep-
tor forms (RPTPβ long and RPTPβ short) and two secreted
molecules (Phosphacan and Phosphacan short isoform (PSI;
Garwood et al., 2003; Chow et al., 2008)). The receptor forms
contain two cytoplasmic tyrosine phosphatase domains, of which
only one is catalytically active (Krueger and Saito, 1992). Sub-
strates for this domain are β-Catenin, which is related to the
Actin cytoskeleton and Wnt signaling (Meng et al., 2000), Fyn
kinase (Pariser et al., 2005a), and others. Dimerization following
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FIGURE 2 | The extracellular matrix after CNS damage. (A, B) After
lesion, cells start to produce an altered extracellular matrix (ECM). One
major source are reactive astrocytes (B) that express CSPGs and other
ECM molecules. (C) Signals come from astrocytes (orange), the
vasculature (red), immune cells/microglia (green), and additional sources
(blue, for a detailed list see Table 1). This environment can promote, but
also inhibit regeneration by affecting neurons, astrocytes, and
oligodendrocytes.
Pleiotrophin binding inactivates the phosphatase domains and
thereby increases the phosphorylation state of downstream factors
like Adducin, a cytoskeletal protein (Pariser et al., 2005b). Other
extracellular interaction partners are TN-C, Contactin/F3/F11,
the cell adhesion molecules L1CAM and NCAM (Klausmeyer
et al., 2007), and FGF (Milev et al., 1998b). RPTPβ isoforms
are regulated after knife lesion of the cerebral cortex (Dobbertin
et al., 2003), striatal stab wound (Barker et al., 1996), and after
retinal laser lesion (Besser et al., 2009) and are critical for recov-
ery (Harroch et al., 2002). PSI as the smallest member of the
RPTPβ family promotes axon growth (Garwood et al., 2003).
Two isoforms (RPTPβ long and Phosphacan) can be decorated
with Chondroitin sulfate GAG chains. These chains regulate the
affinity to binding partners, for example to Contactin/F3/F11
(Milev et al., 1998a). A specific Chondroitin sulfate structure,
the “DSD-1” epitope, is recognized by the monoclonal anti-
body 473HD (Faissner et al., 1994; Gates et al., 1995). This
epitope is expressed on neural stem cells during development
(von Holst et al., 2006) and it has been shown that block-
ing of this epitope impairs neurosphere formation in vitro.
Subpopulations of reactive astrocytes after laser lesion in the
visual cortex of rats and mice express the DSD-1 epitope (Sirko
et al., 2009; Roll et al., 2012). As mentioned above, this might
reflect the immature characteristics of some reactive astrocytes
and at the same time a neurogenic niche-like signal after CNS
damage.
Collagens
Collagens comprise 28 members and can be divided
into fibril-forming and network-forming Collagens
(Ricard-Blum, 2011). In the CNS, Collagens are associated
with the vasculature. Integrins are important Collagen receptors:
the Integrin subunits α1, α2, α10, α11, and β1 interact with
different Collagens. Additional receptors are members of the
Discoidin domain receptors (DDRs), a subfamily of receptor
tyrosine kinases (Leitinger and Hohenester, 2007). In addition
to cell adhesion, Collagens are able to activate intracellular
pathways and can induce proliferation (Pozzi et al., 1998).
Collagens are expressed by astrocytes after lesion. Type IV and
type VIII Collagens, both network-forming and associated with
the basement membrane, have been found upregulated in the
CNS (Liesi and Kauppila, 2002; Hirano et al., 2004). In general,
Collagen expression is suppressed via EGF signaling (Heck et al.,
2007).
Fibronectin
FN is a secreted glycoprotein that forms dimers via disulfide
bonds near the C terminus. FN interacts with ECM molecules
like Collagens, HSPGs, and TN-C and acts as ligand for Integrin
receptors (Singh et al., 2010). FN is expressed by astrocytes
and microglia/macrophages after CNS damage, also liver-derived
plasma FN has a neuroprotective function in CNS repair (Tate
et al., 2007a; Kim et al., 2013). FN activates microglia through
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Table 2 | Parameters modulated by extracellular signals after lesion.
Parameter Modulating factor in the extracellular matrix
Cell survival, Neurotrophic factors*
proliferation Cytokines*
Growth factors*
Differentiation, Agrin
axon growth, Brevican
synaptic plasticity Collagen
Decorin
Glypican
Laminin
Neurocan
Neuron-glial antigen 2 (NG2)
Nogo-A
Phosphacan; with attached DSD-1 epitope
Pleiotrophin
Syndecan
Tenascin-C
Tenascin-R
Thrombospondins
Versican
Migration CXC chemokine ligand 12 (CXCL12)
Fibronectin
Laminin
Tenascin-C
Thrombospondins
Many molecules regulate several aspects, only main functions are listed here.
References are given in the text.
* signaling is modulated by the extracellular matrix.
binding to Integrin α5β1 (Milner et al., 2007) and has a neurite
growth-promoting effect in vitro (Tom et al., 2004).
Heparan sulfate proteoglycans
HSPGs are, in contrast to the inhibitory CSPGs, ascribed to
the neurite outgrowth-promoting factors (Yamaguchi, 2001). It
is assumed that HSPGs can interfere with CSPG signaling by
interacting with the same receptors, for example RPTPσ (Coles
et al., 2011). Accordingly, downstream factors like N-Cadherin
(Siu et al., 2007) might be regulated. The HSPG Glypican is
expressed by reactive astrocytes (Hagino et al., 2003). It is involved
in Hedgehog signaling (Filmus and Capurro, 2014) and as a
HSPG it also regulates FGF signaling (Gordon et al., 1989;
Rapraeger et al., 1991; Yayon et al., 1991). Syndecan, which is also
able to modulate FGF signaling (Filla et al., 1998), is produced
by astrocytes after brain injury (Iseki et al., 2002). Important
for axonal growth and cell migration could be the interaction
of Glypican-1 with repellent Slit proteins (Ronca et al., 2001).
Slit is expressed by reactive astrocytes (Hagino et al., 2003),
treatment with specific inhibitors of this interaction is owing
(Lau and Margolis, 2010). The Drosophila homolog of Syndecan
is involved in Slit signaling (Steigemann et al., 2004), suggesting
a similar effect in the mammalian CNS. The HSPG Agrin is
also expressed by reactive astrocytes. It has functions in the
immune system and in neuromuscular synapse formation and
may additionally play a role in CNS synapse formation during
regeneration (Falo et al., 2008). Perlecan, which is associated
with the vascular basement membrane, is a secreted HSPG that
is upregulated following damage. After stroke, a neuroprotec-
tive effect was shown after administration of Perlecan domain
V. An Integrin-mediated upregulation of VEGF in endothe-
lial cells was attributed to the beneficial function (Lee et al.,
2011).
Laminins
Laminins are trimeric glycoproteins and a crucial component
of the basement membrane. Different isoforms of α, β, and
γ chains are combined to at least 16 Laminins and interac-
tion with other extracellular molecules like Agrin, Collagen IV,
Nidogen, and Perlecan leads to formation of complex networks
(Domogatskaya et al., 2012). Laminins signal through different
Integrins (Belkin and Stepp, 2000) and promote cell adhesion,
migration, and axon growth during development (Calof et al.,
1994). Laminins are upregulated in the glial scar by astro-
cytes (Liesi et al., 1984; McKeon et al., 1995) and in vessels
after lesion (Tate et al., 2007b; Sarkar et al., 2012). CSPG-
mediated inhibition of neurite growth in the scar interferes
with Laminin-induced promoting effects (McKeon et al., 1995).
Migration of activated neural stem cells along vessels after injury
seems to involve Laminin (Kokovay et al., 2010). This could
be mediated by α6β1 Integrin, which is a well-known Laminin
receptor and is expressed on neural stem cells (Shen et al.,
2008).
Tenascins
The TN family comprises four members in vertebrates, namely
TN-C, TN-R, TN-W, and TN-X (Chiquet-Ehrismann et al.,
2014). In the nervous system, TN-C and TN-R are expressed
(Joester and Faissner, 2001). TN-C is a glycoprotein that is
expressed by astrocytes during development and in adult stem
cell niches (Garcion et al., 2004; von Holst, 2008). It has a
modular structure including EGF-like repeats and, as a result
of alternative splicing, a variable number of FN Type III-like
domains (Joester and Faissner, 1999, 2001; von Holst et al., 2007).
As each domain is responsible for specific interactions with other
extracellular molecules, TN-C isoforms have diverse functions.
Six TN-C monomers form a hexamer, called “hexabrachion”.
Expression of different TN-C isoforms is regulated by the tran-
scription factor Pax6 (von Holst et al., 2007). TN-C interacts
with CSPGs, for example with Neurocan (Rauch et al., 1997),
members of the RPTPβ family (Barnea et al., 1994), as well
as with Integrins (Yokosaki et al., 1998) and Contactin/F3/F11
(Rigato et al., 2002). Via its EGF-like repeats, TN-C also binds
to the EGF receptor (Swindle et al., 2001). Interaction of TN-
C has been shown for a number of Integrins, including αvβ3
(Jones and Jones, 2000a). TN-C-induced pathways include RhoA
signaling and a Contactin-dependent inhibition of Fyn kinase. A
model is proposed where inactive Fyn in turn prevents expres-
sion of the splicing factor Sam68 and thereby impairs oligo-
dendrocyte differentiation (Czopka et al., 2010). TN-C blocks
FN-dependent cell migration by interacting with Syndecan-4
(Chiquet-Ehrismann and Chiquet, 2003) and regulates axon
growth (Faissner, 1997). During development, maintenance of
oligodendrocyte precursors (Czopka et al., 2010) and astrocytic
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lineage progression depend on TN-C (Karus et al., 2011). After
lesion, TN-C is re-expressed and it contributes to the glial scar
as barrier (McKeon et al., 1991; Deckner et al., 2000). TN-C is
detected in different regions of the lesioned CNS, for example
in the hippocampus (Niquet et al., 1995; Nakic et al., 1996),
cerebellum, and cortex (Laywell et al., 1992). TN-C expression
was also reported in the human brain after traumatic brain
injury (Hausmann and Betz, 2001). TGF-β and FGF2 stimulate
TN-C expression (Smith and Hale, 1997). After lesion, TN-
C isoforms containing the FN Type III-like domains B and D
are strongly upregulated (Dobbertin et al., 2010). After spinal
cord injury, TN-C has a beneficial effect on spinal cord recov-
ery (Chen et al., 2010). An overview of the different functions
of TN-C is given by Chiquet-Ehrismann et al. (2014). TN-
R has also a modular structure like TN-C, but forms trimers
instead of hexamers (Joester and Faissner, 2001). TN-R inter-
acts with Integrins, for example β1 Integrins (Xu et al., 2014),
Contactin/F3/F11, Phosphacan (Jones and Jones, 2000a), and
Myelin-associated glycoprotein (MAG; Yang et al., 1999). TN-
R is expressed after spinal cord injury (Apostolova et al., 2006)
and in the lesioned optic nerve by an increased number of cells
(Becker et al., 2000). TN-R is part of perineuronal nets (PNNs)
that limit synaptic plasticity in the adult. After damage, this
property seems to inhibit synaptic remodeling and thereby affects
regeneration.
Thrombospondins
TSPs are secreted glycoproteins that form trimers (members
of subgroup A) or pentamers (subgroup B) (Adams and
Lawler, 2011). Interaction partners include ECM molecules like
Laminins, Collagens, and PGs, growth factors like FGF2, and
Integrin receptors that eventually trigger intracellular signaling
cascades (Resovi et al., 2014). Thrombospondins are also involved
in Notch signaling, which regulates astrocytic differentiation after
lesion (Benner et al., 2013). TSPs are expressed by reactive astro-
cytes and microglia (Möller et al., 1996; Lin et al., 2003), for
example they are upregulated after spinal cord injury (Wang
et al., 2009b). TSPs are involved in oligodendrocyte precursor
migration (Scott-Drew and ffrench-Constant, 1997), synapse for-
mation (Christopherson et al., 2005), and angiogenesis inhibition
(Armstrong and Bornstein, 2003).
Cell adhesion molecules
Cell adhesion molecules of the Immunoglobulin superfamily
(IgSF CAMs) are membrane-bound receptors that mediate con-
tact to the ECM and cell-cell interactions. Axon guidance is
one important function of CAMs. Among them, Neural CAM
(NCAM) is upregulated after CNS lesion and promotes spinal
cord recovery (Zhang et al., 2010). Accordingly, recovery in
NCAM knockout mice is affected. The polysialylated form
of NCAM (PSA-NCAM) is associated with plasticity and is
expressed during development, in the adult stem cell niche, and
after CNS damage (Emery et al., 2003). NCAM can modu-
late GDNF and BDNF signaling (Vutskits et al., 2001; Nielsen
et al., 2009) and interacts with the CSPG Neurocan (Fried-
lander et al., 1994). NCAM can activate a number of intra-
cellular cascades, for example the mitogen-activated protein
(MAP) kinase pathway via a complex of Spectrin, RPTPα,
Fyn kinase and Focal adhesion kinase (FAK; Budinich et al.,
2012). L1CAM, another member of IgSF CAMs, is also an
important regulator of axon growth during development. It
is again upregulated after lesions, where it limits corticospinal
tract sprouting (Jakeman et al., 2006). L1CAM activates, in
part together with Integrins, MAP kinase signaling via Src
kinase and Phosphoinositide 3-kinase (PI3K). It also modulates
the Actin cytoskeleton through Ankyrin and Spectrin and can
recruit microtubules via Doublecortin (Maness and Schachner,
2007).
Integrins
Integrins, a group of heterodimer transmembrane receptors for
ECM molecules, are involved in cell adhesion, axon growth, and
numerous other processes. Each Integrin heterodimer consists of
one α and one β subunit. Eighteen α and eight β subunits are
described, leading to 24 confirmed Integrin heterodimers. Inte-
grins connect ECM and the cytoskeleton via adapters like Talin
and activate intracellular pathways that regulate gene expression.
The classical downstream cascade of Integrins leads to activation
of FAK and subsequent activation of Akt and MAP kinases
(Guan, 1997; Guo and Giancotti, 2004). A FAK-independent
activation of Src kinase also exists (Arias-Salgado et al., 2003).
Some Integrins, including the subunits αv, β1, β4, and β7,
can crosstalk with growth factor receptors like EGFR (Brizzi
et al., 2012). The β1 subunit is important in stem cell biology
(Campos, 2005). As already mentioned, Integrins bind a huge
number of ECM molecules. For example, Integrin α6β1 binds
Laminin (Shen et al., 2008) and αvβ3 binds TN-C (Jones and
Jones, 2000b). In addition to these outside-in signaling path-
ways, Integrins can transduce inside-out signals. They are medi-
ated by the cytoskeletal protein Talin and increase the affinity
of Integrin for extracellular ligands (Anthis et al., 2009). Like
their ligands, Integrins are regulated under pathological con-
ditions and contribute to postlesional changes (Ellison et al.,
1999).
Matrix metalloproteinases
MMPs are able to modulate the ECM by specific proteolytic
cleavage (Candelario-Jalil et al., 2009). This function is important
in the damaged CNS when the cells’ environment needs to be
adjusted, for example to increase plasticity. MMP upregulation
following injury is described for blood vessels, astrocytes, and
microglia (Noble et al., 2002). MMPs degrade defined matrix
components. So different TN-C isoforms are cleaved by specific
MMPs (Siri et al., 1995), MMP-3 degrades the CSPGs Neurocan,
Brevican, and Phosphacan (Muir et al., 2002). Effects of MMPs on
regeneration have been described, for example of MMP-9 (Hsu
et al., 2008). Here, migration of MMP-9-deficient astrocytes was
reduced in vitro. MMP-9 is also involved in blood-brain barrier
opening in the diseased CNS (Seo et al., 2013). The expression
of MMPs in astrocytes can be regulated by the cytokines IL-1
and TNF-α (Gottschall and Yu, 1995). But not only migration is
affected by MMPs: MMP-3 and MMP-9 play a role in neuronal
differentiation in response to cytokines in vitro (Barkho et al.,
2008).
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Perineuronal nets
A specialized form of ECM are PNNs. They consist of Hyaluro-
nan, TN-R, the CSPGs Aggrecan, Neurocan, and Brevican, and
link proteins (Faissner et al., 2010; Ye and Miao, 2013). PNNs sur-
round subpopulations of neurons, mostly Parvalbumin-positive
GABAergic inhibitory interneurons, and are thought to stabilize
synapses. Therefore their appearance is correlated with the end
of a critical period during development. It has been shown
that astrocytes play an important role in PNN formation, as
they secrete components of the PNNs (Pyka et al., 2011). In
line with this, the quadruple knockout of TN-C, TN-R, Neu-
rocan, and Brevican either in astrocytes or hippocampal neu-
rons leads to reduced PNN formation, accompanied by impaired
synaptogenesis, synapse stability, and altered synaptic activity in
vitro (Geissler et al., 2013). PNN degradation with the bacterial
enzyme Chondroitinase ABC restored synaptic plasticity in the
visual cortex after the critical period (Pizzorusso et al., 2002).
Although single components like Neurocan can be upregulated
after damage (Kwok et al., 2011), reduction of PNNs has been
described, which is in line with the fact that plasticity is increased
under this condition (Karetko-Sysa et al., 2011). This shows
that not only the presence of molecules as such is important,
but also the spatial distribution and the interaction of different
factors.
GROWTH FACTORS AND OTHER SIGNALING MOLECULES IN THE
MATRIX
Ephrins and Eph receptors
Ephrins and their counterparts, the Eph receptors, are potent reg-
ulators of neurite growth, as they are able to induce growth cone
collapse. Activation of an Eph receptor tyrosine kinase following
Ephrin binding leads to RhoA- and ROCK-induced changes of the
Actin cytoskeleton (Wahl et al., 2000). Also bidirectional signaling
is described, in this case Ephrins can activate RhoA and other
pathways (Daar, 2012). Many Ephrins and Eph receptors are
upregulated after CNS damage, as reviewed by Goldshmit et al.
(2006). Ephrin-B2 and Eph-B2 seem to be involved in segregating
invading fibroblasts at the glial scar (Bundesen et al., 2003).
Nogo-A
Nogo-A is a potent inhibitor of neurite outgrowth and interacts
with a complex of receptors, including NgR1, that results in
activation of ROCK signaling (reviewed by Schmandke et al.,
2014). Nogo-A is produced by oligodendrocytes and is part of
the myelin in the CNS. It is one important inhibitor of axonal
regeneration (Chen et al., 2000). Interestingly, Nogo-A and NgR1
are also involved in the homeostasis of the adult SVZ. Here, pro-
liferation and differentiation of neural stem cells are restricted by
Nogo-A-expressing neuroblasts via NgR1. In addition, neuroblast
migration is regulated by Nogo-A in an NgR1-independent mech-
anism that acts on ROCK (Rolando et al., 2012). Nogo-A and
its receptor have been a target for several blocking experiments
after stroke (Lee et al., 2004), spinal cord injury (Liebscher et al.,
2005), and in other lesion models that showed beneficial effects
of Nogo-A inactivation (reviewed by Overman and Carmichael,
2014; Schwab and Strittmatter, 2014). In intact animals, Nogo-
A blocking showed no obvious side effects on cognitive function
(Craveiro et al., 2013), although the Nogo-A receptor NgR1 is
involved in memory formation (Karlén et al., 2009) and mice with
downregulated Nogo-A show subtle cognitive deficits (Petrasek
et al., 2014).
Semaphorins
Twenty Semaphorins are found in vertebrates, all of them contain
a characteristic extracellular Sema domain. The most promi-
nent function of Semaphorins is the regulation of axon growth
and their ability to induce growth cone collapse. Semaphorins
bind to Plexin and Neuropilin receptors. Different intracellular
cascades eventually affect the cytoskeleton and, in many cases,
induce growth cone collapse. Microtubule and Actin filament
stability can be modified as well as gene expression (Neufeld and
Kessler, 2008), pathways that depend on protein synthesis and
independent mechanisms coexist (Manns et al., 2012). Sema3A
is expressed by fibroblast-like cells after CNS injury (Pasterkamp
et al., 1999) and in line with this, meningeal fibroblasts inhibit
neurite outgrowth in vitro (Niclou et al., 2003). After optic nerve
crush, short-term Sema3A upregulation was observed, whereas
other class 3 Semaphorins were upregulated for days (Sharma
et al., 2012a). L1CAMFc chimeric molecules can reverse the
repellent effect of Sema3A, which shows that the combination of
different factors is important rather than a single factor (Castel-
lani et al., 2000).
Sonic hedgehog
Sonic hedgehog (SHH) is a signaling molecule that is able to
regulate gene expression as well as the cytoskeleton. During devel-
opment, it serves as morphogen and is involved in dorsoventral
patterning. Binding of SHH to its receptor Patched relieves the
repression of the seven-transmembrane receptor Smoothened.
As a consequence, Gli transcription factors are activated and
accumulate in the nucleus. This results in repression or activa-
tion of other transcription factors and altered gene expression
(Fuccillo et al., 2006). Via a Gli-independent mechanism that
involves a guanine nucleotide exchange factor (Tiam1) for the
GTPase Rac1, SHH acts on the cytoskeleton during dendritic
spine formation (Sasaki et al., 2010). SHH is secreted by neurons,
endothelial cells (Sirko et al., 2013), and also by reactive astrocytes
(Amankulor et al., 2009). This upregulation can only be observed
under certain pathological conditions in the CNS. The expres-
sion differs depending on the type of damage. So it is detected
after stab wound and stroke, but not in a murine Alzheimer’s
model (Sirko et al., 2013). In this study, it was shown that SHH
expression is necessary for multipotency of endogenous neural
stem/progenitor cells. The HSPG Glypican, itself upregulated
after damage, is involved in Hedgehog signaling (Filmus and
Capurro, 2014).
Wnts
Secreted Wnt proteins influence gene expression and the
cytoskeleton. The canonical Wnt pathway starts with binding of
Wnt to Frizzled receptor and to the coreceptor LRP. Subsequently,
a β-Catenin-degrading complex is inactivated and β-Catenin
accumulates in the cell. It enters the nucleus, where it interacts
with transcription factors and activates Wnt target genes (Reya
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and Clevers, 2005). Non-canonical Wnt pathways also affect the
cytoskeleton (Semenov et al., 2007). Wnt proteins are upregulated
after lesion and influence regeneration in different ways. It was
shown that repulsive Wnts inhibit axonal growth in the spinal
cord (Liu et al., 2008), on the other hand Wnt signaling is involved
in symmetrical cell division of SVZ cells after stroke (Piccin and
Morshead, 2011).
Notch
Notch is a transmembrane receptor that plays an important role in
neural cell fate determination. After binding of its ligand, Jagged
or Delta-like, the Notch intracellular domain (NICD) is cleaved
by γ-Secretase. NICD translocates to the nucleus, where it inter-
acts with transcription factors and allows target gene expression
(Kopan and Ilagan, 2009). Notch is upregulated and activated
after CNS lesion or stroke (Yamamoto et al., 2001; Xiao et al.,
2009). Notch and its interaction with TSP 4 after cortical lesion
are necessary for the differentiation of SVZ-derived astrocytes
(Givogri et al., 2006; Benner et al., 2013). In another study,
astrogliosis was promoted by the Notch ligand Jagged, produced
by transplanted endothelial progenitor cells (Kamei et al., 2012).
Cytokines
Cytokines induce diverse cellular responses by activation of spe-
cific receptors. Examples for signaling cascades are reviewed
by Leonard and Lin (2000) and Schlessinger and Ullrich
(1992). Important cytokines expressed by activated microglia
and macrophages are Interleukin-1 (IL-1), IL-6, Interferon, and
TNF-α (Smith and Hale, 1997). TGF-β is increased in microglia
under pathological conditions in the brain (Morgan et al., 1993)
and the spinal cord (McTigue et al., 2000). They influence the
expression levels of MMPs (see above) and activate astrocytes,
IL-6 for example promotes EGF-induced astrocyte proliferation
(Levison et al., 2000). Astrocytes are another major cytokine
source (reviewed by Eddleston and Mucke, 1993; Wiese et al.,
2012). BMPs and their inhibitor Noggin regulate neurogenesis in
the adult stem cell niche (Lim et al., 2000). BMPs and Noggin are
upregulated after brain and spinal cord injury (Hampton et al.,
2007) and regulate astrocytic vs. neuronal and oligodendrocytic
differentiation (Xiao et al., 2010). By driving the differentiation of
astrocytes and CSPG production, BMPs are involved in glial scar
formation (Fuller et al., 2007).
Neurotrophic factors
Neurotrophic factors and growth factors signal via specific trans-
membrane receptors. Depending on the class of growth factors,
receptor tyrosine kinases (e.g., EGF receptor) or serine/threonine
receptor kinases (e.g., TGFβ receptor) induce intracellular sig-
naling cascades (Schlessinger and Ullrich, 1992). Neurotrophins
like NT3 bind to Trk (Tropomyosin-related kinase) receptors
(Hetman and Xia, 2000). Neurotrophic factors expressed by
activated microglia and macrophages are BDNF, Ciliary neu-
rotrophic factor (CNTF), Glial cell line-derived neurotrophic
factor (GDNF), Hepatocyte growth factor (HGF), Insulin-like
growth factor (IGF), Nerve growth factor (NGF), Neurotrophin
(NT)-3 and Platelet-derived growth factor (PDGF; reviewed by
Donnelly and Popovich, 2008). Microglia-produced neurotrophic
factors can act in an autocrine way, for example BDNF and NT-3
increase microglia proliferation (Elkabes et al., 1996). In the adult
spinal cord, high levels of CNTF are expressed following injury
(Nakamura and Bregman, 2001). VEGF is secreted by endothelial
cells and after damage also by astrocytes (Nag et al., 2002). It
increases neurogenesis and plasticity (Jin et al., 2002; Licht et al.,
2011). FGF and EGF increase levels of TGF-β (Lindholm et al.,
1992), which is responsible for astrocyte activation and Neurocan
expression (Asher et al., 2000). TGF-β increases NGF levels (Lind-
holm et al., 1990). NGF in turn induces microglial migration via
the TrkA receptor, when combined with low concentrations of
TGF-β (De Simone et al., 2007).
Chemokines
Chemokines are secreted signaling molecules that bind to G
protein-coupled, seven-transmembrane receptors (Salanga et al.,
2009). Activation of a receptor induces a cascade including
second messengers like cAMP or IP3 that can mediate diverse
cellular responses (Patel et al., 2013). The chemokine stromal-
derived factor 1 (SDF-1/CXCL12) is expressed by astrocytes
after stroke and mediates attraction of cells by binding to its
receptor, CXCR4. This system is involved in attraction of bone
marrow stem cells (Hill et al., 2004), transplanted umbilical
cord blood cells (Rosenkranz et al., 2010), and neural stem
cells (Imitola et al., 2004). Two isoforms, SDF-1α and SDF-1β,
have distinct expression patterns in the lesioned CNS. Neurons
express SDF-1α, whereas SDF-1β is expressed by endothelial cells
(Stumm et al., 2002). Hence, a dual function of SDF-1-mediated
modulation of the immune response and neurotransmission is
discussed.
REGENERATION IN ECM KNOCKOUT (KO) MODELS
The effect of ECM molecules on regeneration was examined in
different knockout models. Double knockout of Neurocan and
Brevican in mice does not obviously affect recovery after spinal
cord injury (Quaglia et al., 2008). In a more sophisticated model
with an additional priming lesion in the sensory nerve 7 days
after spinal cord injury, only in KO animals axons crossed the
dorsal root entry zone. This uncovered the growth-inhibiting
effect of Neurocan and Brevican in the wild-type situation. TN-
C KO mice have a mild phenotype, but recover worse after
spinal cord injury (Chen et al., 2010). In contrast, deficiency
of TN-R improves functional recovery of mice after spinal cord
injury (Apostolova et al., 2006). TN-R seems to restrict synaptic
reorganization after injury, which is in line with the role of TN-R
in PNNs. EphA4 KO mice exhibit reduced gliosis and improved
functional recovery after spinal cord injury (Goldshmit et al.,
2004). Therefore, EphA4 seems to regulate two important aspects
in regeneration.
EXTRACELLULAR MATRIX AS TARGET FOR IMPROVED RECOVERY
Inhibitory matrix was the target of different approaches so far,
a number of studies have been reviewed by Soleman et al.
(2013). The function can be blocked with antibodies, spe-
cific inhibitors, by knockdown, or already synthetized ECM
can proteolytically be degraded, for example by ADAM pro-
teases (reviewed by Burnside and Bradbury, 2014). Inhibition
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of proteoglycan synthesis by β-D-Xylosides and sodium chlorate
eliminates the inhibitory effect of astrocytic matrix on neurite
growth in vitro (Smith-Thomas et al., 1995). Treatment with
the Chondroitin sulfate-degrading enzyme Chondroitinase ABC
(ChABC) revealed a recovery-promoting effect after spinal cord
injury (Bradbury et al., 2002) and had neuroprotective effects
(Chen et al., 2014). Although ChABC treatment is effective
in many cases, ChABC-resistant inhibitory matrix also remains
(Siddiqui et al., 2009) that needs to be addressed by other
strategies. These inhibitory signals can be ascribed to the core
protein part of PGs or to other molecules in the matrix. Treat-
ment with antibodies directed against an extracellular factor
relies on blocking its function. Studies using antibodies against
Nogo-A (Zhao et al., 2013) and TN-R (You et al., 2012) have
shown improved recovery from spinal cord injury. In addition
to the aforementioned strategies that rely on the elimination of
ECM function, delivery of regeneration-promoting ECM-related
molecules is possible. For example, transplantation of L1CAM-
overexpressing neural aggregates improved regeneration more
effectively than those with normal L1CAM expression levels (Cui
et al., 2011).
Possible mechanisms by which transplanted stem cells can
promote regeneration in the context of ECM are discussed in the
following third section.
POTENTIAL EFFECTS OF ENDOGENOUS AND
TRANSPLANTED STEM CELLS ON REGENERATION
As described in the first section, endogenous progenitor-like cells
appear in the damaged CNS. If a subset of astroglial cells starts to
de-differentiate anyway, what could be the benefit of additional,
transplanted stem cells? It is clear that in many cases positive
effects are not due to cell replacement (Chopp et al., 2009).
The last section of this review gives an overview of the different
strategies behind stem cell therapies.
What are potential mechanisms by which transplanted stem
cells support regeneration? Several strategies to improve recovery
have been pursued so far (Burda and Sofroniew, 2014). Roughly
the effects can be divided into three main aspects: (i) immune
modulation; (ii) support of cell survival, differentiation, or axonal
growth; and (iii) cell replacement (summarized in Figure 3A).
Examples for factors that are produced by stem cells and their
FIGURE 3 | Stem cell treatment and time line after CNS damage. (A)
Stem cell transplantation can promote recovery by different mechanisms.
Modulation of (i) the immune response; (ii) production of factors that
regulate survival, differentiation, or axon growth; and (iii) cell replacement
are possible mechanisms. (B) In a first phase, cell death and
inflammation (ca. 2 weeks) predominate, followed by a phase of tissue
replacement (days to weeks) and tissue remodeling (months to years).
This limits the time frame for efficient stem cell treatment, as shown for
different aspects involved in regeneration. (B) Modified from Burda and
Sofroniew (2014).
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Table 3 | Aspects potentially influenced by transplanted stem cells.
Parameter Stem cell-released factor
Immune system modulation Chondroitin sulfate proteoglycans (CSPGs)
Prostaglandin E
Tenascin-C
Neuroprotection Glial cell line-derived neurotrophic
factor (GDNF)
Nerve growth factor (NGF)
Axon growth, Matrix metalloproteinases (MMPs)
differentiation, Neurocan
synaptic plasticity Phosphacan; with attached DSD-1 epitope
Tenascin-C
Tissue inhibitors of metalloproteinase
(TIMPs)
References are given in the text.
potential effects on regeneration are listed in Table 3. With regard
to the phases of regeneration, where a first phase of cell death
and inflammation (ca. 2 weeks) is followed by a phase of tissue
replacement (days to weeks) and finally by tissue remodeling
(months to years), at each time point different mechanisms
have priority. This limits the time frame for efficient stem cell
treatment (Figure 3B). Depending on the desired effect, stem
cells of different origin and of different potential are the first
choice.
The following aspects may account for differences of cul-
tured and transplanted cells in comparison to the endogenous
stem/progenitor pool: (i) the cell number of stem/progenitor cells
may be higher when additional cells are transplanted; (ii) the
potential of the cultured cells may differ from their endogenous
counterparts due to the treatment (stress, addition of factors to
the medium, etc.); (iii) not only the potential to differentiate
may be changed during culture, but also the factors these cells
secrete could differ depending on the pretreatment, the origin, or
the differentiation state; (iv) transplantation of stem cells could
modulate the immune system and therefore act indirectly on the
CNS; and (v) stem cells can also be used as vehicle: for exam-
ple, genetically modified stem cells stably deliver neurotrophic
or other factors to damaged tissue, e.g., CNTF (Jung et al.,
2013).
INTERACTION OF STEM CELLS AND THE IMMUNE SYSTEM
Immune cells can have both, positive and detrimental effects
on regeneration, but also on the fate of endogenous and trans-
planted stem cells (reviewed by Martino et al., 2011; Kokaia et al.,
2012). On the other hand, stem cells can modulate the immune
response. For example, it has been shown that neurosphere-
derived multipotent progenitors have a neuroprotective effect by
immune modulation (Pluchino et al., 2005). Systemically trans-
planted NSCs improved recovery in a stroke model and reduced
the expression of inflammation-associated genes (Bacigaluppi
et al., 2009). Stem cells can also suppress T lymphocytes via
increased nitric oxide and Prostaglandin E levels (Wang et al.,
2009a).
In addition to the typical immune modulators mentioned
above, molecules of the ECM can also influence the immune
system: CSPGs do not only regulate axon growth, they are also
able to modulate the immune response by binding to cytokines
and Cluster of differentiation 44 (CD44; reviewed by Haylock-
Jacobs et al., 2011). TN-C, a glycoprotein that is secreted by
neural stem/progenitor cells in vitro (von Holst et al., 2007),
can influence the immune system via Toll-like receptor (TLR)
4 (Midwood et al., 2009). TN-C and the immune system influ-
ence each other reciprocally: TN-C modulates the immune
response, but is itself regulated by cytokines during inflammation.
A detailed description is given in the review by Jakovcevski
et al. (2013). Not only neural stem/progenitor cells can be uti-
lized to improve recovery. For example, bone marrow stromal
cells/mesenchymal stem cells (MSCs) reduce microglial activation
(Yan et al., 2013). In addition to secreted factors, in the last
years the role of exosomes in intercellular communication is
being discussed (Ludwig and Giebel, 2012). These small vesicles
loaded with lipids, proteins, and RNAs are released by MSCs
and other cell types and might represent a mechanism by which
transplanted cells can influence the immune system (Kordelas
et al., 2014).
PRODUCTION OF NEUROTROPHIC FACTORS AND
REGULATION OF PLASTICITY
As described, stem cells can support neuronal survival by mod-
ulating the immune response, but they can also have a direct
neuroprotective effect. Stem cells produce neurotrophic factors
like GDNF and NGF (Lladó et al., 2004). Furthermore, they
express a number of ECM molecules that are present in the devel-
oping nervous system. Among them are CSPGs like Neurocan,
Phosphacan carrying the DSD-1 epitope (Ida et al., 2006; von
Holst et al., 2006) and, as already mentioned, the glycoprotein
TN-C. Some of these factors are well-known for their impact
on cell differentiation, migration, and axon growth. If these
factors are able to influence regeneration after transplantation
will mostly depend on the number of surviving cells. A positive
effect of human neural progenitor cells on axonal transport and
plasticity after stroke was in part attributed to VEGF, TSP and Slit
expression (Andres et al., 2011). Transplanted cells that express
MMPs or they counterparts, the Tissue inhibitors of metallo-
proteinases (TIMPs), can control the ECM composition. Also
non-neural cells can affect plasticity. So expression of MMPs and
TIMPs was shown in MSCs, with differences in the expression
profile depending on the origin of the cells (Lozito et al., 2014).
MSCs induce SHH expression in host astrocytes that increases
plasticity in conjunction with tissue-type plasminogen activator
(tPA; Samson and Medcalf, 2006; Ding et al., 2013).
Plasticity can be induced not only on the molecular level.
Neural precursors transplanted into the visual cortex differenti-
ated into inhibitory neurons and formed synapses to host cortical
neurons, thereby promoting plasticity after the critical period
(Southwell et al., 2010).
NEURAL DIFFERENTIATION AND CELL REPLACEMENT BY
TRANSPLANTED STEM CELLS
Embryonic stem (ES) cells provide a source for the different cell
types, because as pluripotent cells they can give rise to all cell types
of the body, including neurons, astrocytes, and oligodendrocytes
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(Fraichard et al., 1995). To avoid the ethically problematic use of
the embryo-derived ES cells, alternative sources for pluripotent
cells were investigated. A promising alternative was described in
2006, when fibroblasts were reprogrammed to induced pluripo-
tent stem cells (iPSCs; Takahashi and Yamanaka, 2006). The
“Yamanaka cocktail” contains the four factors Oct3/4, Sox2, c-
Myc, and Klf4. Subsequently, the number of factors could be
reduced to two when adult neural stem cells were reprogrammed
to iPSCs (Kim et al., 2008). Meanwhile, direct conversion of
fibroblasts to induced neural stem cells (iNSCs) without a
pluripotent state has been described (Han et al., 2012; Thier et al.,
2012), reducing the risk of tumor induction by undifferentiated
cells.
Cell fate decisions can be regulated, so astrocytic differentia-
tion of transplanted NSCs is reduced when the CNTF is neutral-
ized (Ishii et al., 2006). Astrocytes can be driven to a glutamater-
gic, NG2 glia to a glutamatergic and GABAergic neuronal cell
fate by retroviral expression of the transcription factor NeuroD1
(Guo et al., 2014). Procedures for the directed differentiation
into distinct neuronal subtypes exist, where cells are exposed
to defined soluble and surface-bound factors. For example, glu-
tamatergic (Zeng et al., 2010) and GABAergic (Maroof et al.,
2013) neurons can be derived from ESCs or iPSCs. Also regional
identities like retinal progenitors (Lamba et al., 2006) and sub-
sequently photoreceptors can be produced (Lamba et al., 2010).
But not only neurons, also oligodendrocytes as the myelinating
cells of the CNS are important for regeneration and proto-
cols are described that promote this cell fate (Neman and de
Vellis, 2012). Functional integration of such cells was already
shown, also for human cells (Tornero et al., 2013). A combined
approach of stem cell-based treatment and manipulation of the
ECM is the injection of neural stem cells with Chondroiti-
nase ABC into the lesioned spinal cord (Ikegami et al., 2005).
Axonal regrowth was significantly increased by the combined
application.
SUMMARY/OUTLOOK
As shown in this review, the CNS reacts to damage by upreg-
ulation of numerous extracellular signaling molecules that in
part resemble the neurogenic stem cell niche. In line with this,
endogenous stem/progenitor-like cells can be observed in many
lesion models. The ECM contains important regulators of cell
survival, differentiation, migration, or neurite outgrowth and is
able to modulate signaling of associated molecules, for example
of growth factors. These signals and the intrinsic properties of
the cells present in the lesioned CNS are responsible for the
outcome after regeneration. Stem cell transplantation now aims
to influence this system or to add cells that replace lost tissue
to a certain degree. Some approaches exploit neuroprotective
effects by the stem cells, whereas others depend on cell replace-
ment after differentiation and functional integration of the cells.
The latter requires a carefully orchestrated sequence of complex
actions and therefore seems to be harder to achieve. Stem cell
transplantation experiments in animals will help to learn more
about the molecular mechanisms that influence regeneration,
as they allow to manipulate specific aspects in this complex
interplay.
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